7776 CellSeed
- 841
- +42+5.26%
CellSeed News
CellSeed: Confirmatory letter.
CellSeed: Interim Report - 24th Fiscal Year (January 1, 2024 - June 30, 2024)
CellSeed: Announcements of individual stocks regarding recognition of non-operating income and expenses and special income and expenses
CellSeed: Short message on accounting settlement for the 2nd quarter (interim period) of fiscal year ending December 2024 [Japanese standard] (non-consolidated).
CellSeed: Announcements of individual stocks regarding the mass exercise status and completion of the 24th subscription rights (with exercise price adjustment clause).
CellSeed: Announcements of subscription rights for the 24th term, including the monthly exercise status with the price adjustment clause.
CellSeed: Announcements of individual stocks regarding the patent evaluation of the US application for the "cartilage regeneration seat" for transplantation.
CellSeed: Announcements of individual stocks regarding the allocation status of procurement funds and change of fund usage related to the 23rd subscription rights (with revised exercise price clause).
CellSeed: Change report (exemption share certificates, etc.)
CellSeed: Notice regarding the monthly exercise status of the 24th Stock Acquisition Rights (with exercise price amendment clause)
CellSeed: Change Report
CELLSEED: Notice Concerning the 24th Mass Exercise of Stock Acquisition Rights (with Exercise Price Amendment Clause)
CELLSEED: Change Report
CELLSEED: Change Report
CELLSEED: Quarterly Report - 1st quarter of the 24th period (2024/01/01 to 2024/03/31)
CELLSEED: Confirmation letter
CELLSEED: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
CELLSEED: Notice Concerning the Recording of Non-Operating Income and Extraordinary Profit
CELLSEED: Change Report
CELLSEED: Notice regarding the monthly exercise status of the 24th Stock Acquisition Rights (with exercise price amendment clause)
Analysis
Price Target
No Data
No Data